{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:31:25Z","timestamp":1791189085280,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Grants-in-Aid for Scientific Research","award":["21591144"],"award-info":[{"award-number":["21591144"]}]},{"name":"20390259"},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.bbrc.2014.12.063","type":"journal-article","created":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T04:33:49Z","timestamp":1419050029000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-\u03b3 activation"],"prefix":"10.1016","volume":"457","author":[{"given":"Kazuki","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Senokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarie","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiko","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saya","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Motoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kukidome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.12.063_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(99)00525-2","article-title":"The evolving role of statins in the management of atherosclerosis","volume":"35","author":"Vaughan","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0010","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/hq1101.098486","article-title":"Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors","volume":"21","author":"Takemoto","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0015","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","article-title":"Antiatherothrombotic properties of statins: implications for cardiovascular event reduction","volume":"279","author":"Rosenson","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2014.12.063_b0020","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2014.12.063_b0025","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0735-1097(97)00324-0","article-title":"HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia","volume":"30","author":"Weber","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0030","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1074\/jbc.M412531200","article-title":"Statins suppress oxidized low-density lipoprotein-induced macrophage proliferation by inactivation of small G protein-p38 MAPK pathway","volume":"280","author":"Senokuchi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.12.063_b0035","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0735-1097(97)00537-8","article-title":"Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys","volume":"31","author":"Willaims","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0040","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/01.CIR.97.24.2433","article-title":"Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization","volume":"97","author":"Aikawa","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2014.12.063_b0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.ATV.17.2.265","article-title":"Vastatins inhibit tissue factor in cultured human macrophages: a novel mechanism of protection against atherothrombosis","volume":"17","author":"Colli","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.ATV.13.4.571","article-title":"HMG CoA reductase inhibitors: in vivo effects on carotid intimal thickening in normocholesterolemic rabbits","volume":"13","author":"Soma","year":"1993","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.bbrc.2014.12.063_b0055","doi-asserted-by":"crossref","first-page":"37731","DOI":"10.1074\/jbc.R100034200","article-title":"PPAR\u03b3: a nuclear regulator of metabolism, differentiation, and cell growth","volume":"276","author":"Rosen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.12.063_b0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1471-4892(03)00014-6","article-title":"PPAR agonists in the treatment of atherosclerosis","volume":"3","author":"Francis","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0065","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI10370","article-title":"Peroxisome proliferator-activated receptor \u03b3 ligands inhibit development of atherosclerosis in LDL receptor-deficient mice","volume":"106","author":"Li","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2014.12.063_b0070","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/01.RES.0000268411.49545.9c","article-title":"Statins activate peroxisome proliferator-activated receptor \u03b3 through extracellular signal-regulated kinase 1\/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages","volume":"100","author":"Yano","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2014.12.063_b0075","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.RES.0000185823.73556.06","article-title":"Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression","volume":"97","author":"Igata","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2014.12.063_b0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diabetes.55.01.06.db05-0943","article-title":"Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells","volume":"55","author":"Kukidome","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2014.12.063_b0085","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/ATVBAHA.110.222067","article-title":"Telmisartan exerts anti-atherosclerotic effects by activating PPAR\u03b3 in macrophages","volume":"31","author":"Matsumura","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0090","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1074\/jbc.M703318200","article-title":"Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-\u03b1 (PPAR\u03b1) and PPAR\u03b3 through MAPK-dependent COX-2 expression in macrophages","volume":"283","author":"Taketa","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.12.063_b0095","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.RES.0000146672.10582.17","article-title":"Chemokines in the pathogenesis of vascular disease","volume":"95","author":"Charo","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2014.12.063_b0100","doi-asserted-by":"crossref","first-page":"H1069","DOI":"10.1152\/ajpheart.00143.2005","article-title":"Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling","volume":"289","author":"Yang","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0105","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/01.ATV.0000090130.85752.ED","article-title":"Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development","volume":"23","author":"Hao","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.hco.0000181482.99067.bf","article-title":"The pleiotropic effects of statins","volume":"20","author":"Calabr\u00f2","year":"2005","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0115","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/01.ATV.19.6.1518","article-title":"Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice","volume":"19","author":"Aiello","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1097-2765(00)80139-2","article-title":"Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice","volume":"2","author":"Gu","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2014.12.063_b0125","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/01.ATV.21.6.937","article-title":"HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress","volume":"21","author":"Yasunari","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0130","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.bbrc.2006.07.204","article-title":"Pitavastatin attenuates the PDGF-induced LR11\/uPA receptor-mediated migration of smooth muscle cells","volume":"348","author":"Jiang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.12.063_b0135","doi-asserted-by":"crossref","first-page":"15099","DOI":"10.1074\/jbc.M600200200","article-title":"Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin","volume":"281","author":"Chandrasekar","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.12.063_b0140","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0022-3565(24)36722-9","article-title":"Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation","volume":"281","author":"Raiteri","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2014.12.063_b0145","first-page":"L55","article-title":"Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells","volume":"275","author":"Jr Stark","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0150","doi-asserted-by":"crossref","first-page":"21926","DOI":"10.1074\/jbc.274.31.21926","article-title":"3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1)","volume":"274","author":"Laufs","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.12.063_b0155","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1161\/01.CIR.0000074040.31731.96","article-title":"Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation","volume":"107","author":"de Dios","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2014.12.063_b0160","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.101.11.1311","article-title":"Expression and function of PPARgamma in rat and human vascular smooth muscle cells","volume":"101","author":"Law","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2014.12.063_b0165","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.109.184234","article-title":"Dominant-negative loss of PPARgamma function enhances smooth muscle cell proliferation, migration, and vascular remodeling","volume":"29","author":"Meredith","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2014.12.063_b0170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.atherosclerosis.2009.02.014","article-title":"Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation","volume":"206","author":"Nakamura","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2014.12.063_b0175","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/01.HYP.0000145179.44166.0f","article-title":"Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis","volume":"44","author":"Li","year":"2004","journal-title":"Hypertension"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14022451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14022451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:29:06Z","timestamp":1747240146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14022451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0006291X14022451"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.12.063","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-\u03b3 activation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.12.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}